Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

Clinical trial NCT04282018 · COMPLETED

Trial details

NCT number: NCT04282018
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Follicular Lymphoma Marginal Zone Lymphoma Mantle Cell Lymphoma Diffuse Large B Cell Lymphoma Advanced Solid Tumor

Start date: 2020-04-29
Primary completion: 2024-08-28
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.